NCT03116165

Brief Summary

This study will examine the use of modified prolonged exposure therapy in trauma patients recently exposed to trauma in an emergency room to prevent the onset of post-traumatic stress disorder.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
352

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 3, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 14, 2017

Completed
4 days until next milestone

Study Start

First participant enrolled

April 18, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 11, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 11, 2017

Completed
Last Updated

May 17, 2018

Status Verified

May 1, 2018

Enrollment Period

8 months

First QC Date

April 3, 2017

Last Update Submit

May 13, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • CLINICIAN-ADMINISTERED PTSD SCALE for Diagnostic and Statistical Manual of Mental Disorders-5 (CAPS)

    Clinical interview that gives a continuous measure of PTSD severity and dichotomous diagnosis of PTSD

    Change 2-, 6- (primary endpoint) and 12 months after intervention

Secondary Outcomes (10)

  • PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-5 (PCL-5)

    Change 2-, 6- (primary endpoint) and 12 months after intervention

  • Montgomery Åsberg Depression Rating Scale - Self-report (MADRS-S)

    Change from baseline to 2, 6 (primary endpoint) and 12 months after intervention

  • Euroqol (EQ-5D)

    Measured 6 months after intervention

  • WHO Disability Assessment Schedule (WHODAS)

    Change 2-, 6- (primary endpoint) and 12 months after intervention

  • Adverse events

    Change 2-, 6- (primary endpoint) and 12 months after intervention

  • +5 more secondary outcomes

Study Arms (2)

Modified prolonged exposure therapy

EXPERIMENTAL

Participants will receive three sessions of modified prolonged exposure therapy.

Behavioral: Modified prolonged exposure therapy

Attention control

PLACEBO COMPARATOR

Participants will receive three sessions of supportive counselling and psychoeducation

Behavioral: Attention control

Interventions

Participants will receive three sessions of modified prolonged exposure therapy.

Modified prolonged exposure therapy

Participants will receive three sessions of supportive counselling and psychoeducation

Attention control

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Presenting to the emergency department at the Karolinska University hospital Solna in the past 72 hours before the intervention
  • Meets diagnostic criterion A for post-traumatic stress disorder in the fifth version of Diagnostic and Statistical Manual of Mental Disorders, DSM-5

You may not qualify if:

  • Do not want to participate in the study
  • Ongoing intoxication (e.g. severe alcohol intoxication)
  • Other serious psychiatric comorbidity that demands attention (e.g. manic episode, acute suicidal ideation)
  • Not oriented
  • Not having a memory ot the tramatic event

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska Institutet

Stockholm, 17177, Sweden

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 3, 2017

First Posted

April 14, 2017

Study Start

April 18, 2017

Primary Completion

December 11, 2017

Study Completion

December 11, 2017

Last Updated

May 17, 2018

Record last verified: 2018-05

Locations